Hypoxia-inducible Factor-1 in Myocardial Ischaemia/reperfusion Injury
Overview
Authors
Affiliations
The mTOR Signaling Pathway: Key Regulator and Therapeutic Target for Heart Disease.
Wang J, Huang Y, Wang Z, Liu J, Liu Z, Yang J Biomedicines. 2025; 13(2).
PMID: 40002810 PMC: 11853667. DOI: 10.3390/biomedicines13020397.
Zhang Z, Liu Y, Huang D, Huang Z J Inflamm Res. 2024; 17:6203-6227.
PMID: 39281774 PMC: 11397271. DOI: 10.2147/JIR.S476456.
Insulin-like growth factor-1 in myocardial ischemia-reperfusion injury: A review.
Yan Z, Xing Z, Xue T, Zhao J, Li G, Xu L Medicine (Baltimore). 2024; 103(9):e37279.
PMID: 38428899 PMC: 10906579. DOI: 10.1097/MD.0000000000037279.
Liu P, Huang J, Mei W, Zeng X, Wang C, Wen C Bioengineered. 2021; 12(2):9496-9506.
PMID: 34699312 PMC: 8810140. DOI: 10.1080/21655979.2021.1996018.
HIF‑1α in myocardial ischemia‑reperfusion injury (Review).
Zheng J, Chen P, Zhong J, Cheng Y, Chen H, He Y Mol Med Rep. 2021; 23(5).
PMID: 33760122 PMC: 7974458. DOI: 10.3892/mmr.2021.11991.